Compounds > gp 1-515
Page last updated: 2024-09-03

gp 1-515 and adenosine

gp 1-515 has been researched along with adenosine in 4 studies

Compound Research Comparison

Studies
(gp 1-515)		Trials
(gp 1-515)		Recent Studies (post-2010)
(gp 1-515)		Studies
(adenosine)		Trials
(adenosine)		Recent Studies (post-2010) (adenosine)
80032,5361,0758,930

Protein Interaction Comparison

ProteinTaxonomygp 1-515 (IC50)adenosine (IC50)
high affinity choline transporter 1 isoform aHomo sapiens (human)0.3851
Sodium/nucleoside cotransporter 1Homo sapiens (human)5.5
Sodium/nucleoside cotransporter 2Homo sapiens (human)5.5
Adenosine receptor A3Homo sapiens (human)0.0011
Adenosine receptor A1Homo sapiens (human)0.0023
Equilibrative nucleoside transporter 1Homo sapiens (human)63
Solute carrier family 28 member 3Homo sapiens (human)3.3

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barankiewicz, J; Bullough, DA; Erion, MD; Firestein, GS; Gruber, HE; Jimenez, R; Mullane, KM; Ramirez-Weinhouse, M; Smith, CW1
Cronstein, BN; Firestein, G; Naime, D1
Boyle, D; Bullough, DA; Firestein, GS; Gruber, HE; Montag, A; Mullane, KM; Sajjadi, FG; Sambol, B1
Boyle, D; Eigler, A; Endres, S; Erhardt, S; Firestein, GS; Hartmann, G; Matschke, V1

Other Studies

4 other study(ies) available for gp 1-515 and adenosine

ArticleYear
Inhibition of neutrophil adhesion by adenosine and an adenosine kinase inhibitor. The role of selectins.
    Journal of immunology (Baltimore, Md. : 1950), 1995, Jan-01, Volume: 154, Issue:1

    Topics: 2-Chloroadenosine; Adenosine; Adenosine Kinase; CD18 Antigens; Cell Adhesion; Cell Adhesion Molecules; Cells, Cultured; Cytoskeleton; Depression, Chemical; E-Selectin; Endothelium, Vascular; Humans; Interleukin-1; L-Selectin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Ribonucleosides

1995
The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine.
    Arthritis and rheumatism, 1995, Volume: 38, Issue:8

    Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Leukocytes; Mice; Mice, Inbred BALB C; Purinergic P1 Receptor Antagonists; Ribonucleosides; Theobromine; Tumor Necrosis Factor-alpha; Xanthines

1995
Protective effect of an adenosine kinase inhibitor in septic shock.
    Journal of immunology (Baltimore, Md. : 1950), 1994, Jun-15, Volume: 152, Issue:12

    Topics: Adenosine; Adenosine Kinase; Animals; Bacterial Infections; Base Sequence; Disease Models, Animal; DNA, Complementary; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Neutrophils; Peritonitis; Rats; Ribonucleosides; Shock, Septic; Tumor Necrosis Factor-alpha

1994
Suppression of TNF-alpha production in human mononuclear cells by an adenosine kinase inhibitor.
    Journal of leukocyte biology, 2000, Volume: 68, Issue:1

    Topics: Adenosine; Adenosine Kinase; Adenosine Monophosphate; Adult; Anti-Inflammatory Agents, Non-Steroidal; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Depression, Chemical; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Inhibitors; Humans; Interleukin-10; Leukocytes, Mononuclear; Phosphodiesterase Inhibitors; Ribonucleosides; Rolipram; Second Messenger Systems; Thionucleotides; Tumor Necrosis Factor-alpha

2000